Human thioredoxin

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 235, 530350, 4353201, 435 691, 435 693, 435 6, 435273, 4352523, C07H 2102, C07H 2104

Patent

active

058310495

ABSTRACT:
The present invention provides a human thioredoxin (TRDX) and polynucleotides which identify and encode TRDX. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding TRDX and a method for producing TRDX. The invention also provides for agonists, antibodies, or antagonists specifically binding TRDX, and their use, in the prevention and treatment of diseases associated with expression of TRDX. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding TRDX for the treatment of diseases associated with the expression of TRDX. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding TRDX in the production of recombinant proteins. The invention also provides for the use of purified TRDX in the production of recombinant proteins. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding TRDX.

REFERENCES:
Loferer, H., et al., "A Bacterial Thioredoxin-like Protein That Is Exposed to the Periplasm Has Redox Properties Comparable with Those of Cytoplasmic Thioredoxins," The Journal of Biological Chemistry, 270(44):26178-26183.
Holmgren, A., "Thioredoxin," Ann. Rev. Biochem., 54:237-271 (1985).
Abate, C., et al., "Redox Regulation of Fos and Jun DNA-Binding Activity in Vitro," Science, 249:1157-1161 (1990).
Tagaya, Y., et al., "ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction," The EMBO Journal, 8(3)757-764 (1989).
Wakasugi, H., et al., "Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor," Proc. Natl. Acad. Sci. USA, 84:804-808 (1987).
Rosen, A., et al., "A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin," International Immunology, 7(4) 625-633 (1994).
Miranda-Vizuete, A., et al., "The Levels of Ribonucleotide Reductase, Thioredoxin, Glutaredoxin 1, and GSH are Balanced in Escherichia coli K12*," The Journal of Biological Chemistry, 271(32) 19099-19103 (1996).
Yamauchi, A., et al., "Lymphocyte Transformation and Thiol Compounds; the Role of ADF/Thioredoxin as an Endogenous Reducing Agent," Molecular Immunology, 29(2):263-270 (1992).
Watabe, S. (GI 1545817) GenBank Sequence Database (Accession N30487) National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland 2084.
Luthman, M., et al., "Rat Liver Thioredoxin and Thioredoxin Reductase: Purification and Characterization," Biochemistry, 21:6628-6633.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Human thioredoxin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human thioredoxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human thioredoxin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-690630

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.